A new wave of biotech venture capital firms, led by younger investors, is reshaping the industry with fresh strategies and a ...

Vineeta Agarwala at a16z discusses new venture, Pres. Trump's jobs cuts across all federal health agencies and how the US can remain competitive with rise in biotech deals in China.

Trimtech Therapeutics has closed a seed funding round of $31m (£25m) to advance its pipeline of the central nervous system ...

Up to 60 new life sciences companies are set to benefit from 1.2 billion euros ($1.27 billion) that Sofinnova Partners has ...

TRIMTECH Therapeutics raises $31M to enhance its TRIMTAC platform, targeting protein aggregates in neurodegenerative diseases for improved therapeutic outcomes.

DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the evolving Metabolic Dysfunction-Associated Steatohepatitis (MASH) market ...

TRIMTECH Therapeutics’s incredible $31million seed funding haul will be deployed to develop treatments for severe ...

Insilico Medicine Inc. is considering an initial public offering after securing funding at a valuation of more than $1 ...

Cambridge biotech TRIMTECH Therapeutics, which is harnessing targeted protein degradation for the treatment of neurodegenerative diseases, has closed an oversubscribed $31 million (£25m) seed round ...

A steady supply of weight-loss drugs Wegovy and Mounjaro has helped lift Eucalyptus’ revenue from $78 million to $121 million ...